Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug 12;173(15):1465-6.
doi: 10.1001/jamainternmed.2013.6895.

Trends in androgen prescribing in the United States, 2001 to 2011

Jacques Baillargeon  1 , Randall J Urban, Kenneth J Ottenbacher, Karen S Pierson, James S Goodwin
Affiliations

Trends in androgen prescribing in the United States, 2001 to 2011

Jacques Baillargeon et al. JAMA Intern Med. .

Erratum in

  • JAMA Intern Med. 2013 Aug 12;173(15):1477
No abstract available

PubMed Disclaimer

References

    1. Bhasin S, Singh AB, Mac RP, Carter B, Lee MI, Cunningham GR. Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan. J Androl. 2003;24(3):299–311. - PubMed
    1. US Food and Drug Administration [December 1, 2012];Postmarket review. 2009 http://www.fda.gov/advisorycommittees/.
    1. Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med. 2010;363(2):109–122. - PMC - PubMed
    1. Calof OM, Singh AB, Lee ML, et al. Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci. 2005;60(11):1451–1457. - PubMed
    1. Haddad RM, Kennedy CC, Caples SM, et al. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc. 2007;82(1):29–39. - PubMed

Publication types